HIV-1 RNA DETECTION BY REAL TIME PCR (QUALITATIVE)^

The HIV-1 RNA Detection by Real Time PCR (Qualitative) is a molecular diagnostic test that detects the presence or absence of HIV‑1 genetic material (viral RNA) in a patient specimen. The assay uses real‑time polymerase chain reaction (PCR) technology to amplify and identify viral RNA with high sensitivity, making it particularly valuable for early detection of infection before antibodies are detectable.

This qualitative PCR is primarily used to confirm suspected acute HIV infection, to evaluate inconclusive serology results, and for testing exposed newborns where maternal antibodies may interfere with standard antibody tests. Samples are processed in accredited Dubai/UAE laboratories, and Touch Connect offers discreet home phlebotomy and confidential reporting to ensure privacy and fast turnaround for clinically actionable results.

• HIV‑1 RNA (Qualitative)
• Detected / Not Detected (Presence of HIV‑1 viral RNA)
• Assay reporting threshold (qualitative detection limit)
• Specimen type: Plasma (EDTA) noted on report

• After a recent high‑risk exposure (for early detection within days to weeks)
• If experiencing acute retroviral syndrome symptoms (fever, rash, sore throat, swollen glands)
• When antibody/antigen tests are non‑reactive or indeterminate but clinical suspicion remains
• For newborns of HIV‑positive mothers where maternal antibodies may confound serology
• To evaluate suspected infection during post‑exposure prophylaxis (PEP) follow‑up

• Detects HIV‑1 very early in infection—before antibodies are present
• High analytical sensitivity and specificity using real‑time PCR
• Discreet home sample collection by trained phlebotomists across Dubai and the UAE
• Fast processing in accredited laboratories with confidential result delivery
• Useful when serology is inconclusive or for testing neonates

• Venous blood sample (plasma in EDTA) collected by a trained phlebotomist at home
• No fasting required; hydrate normally prior to collection
• Provide recent exposure history and current/previous antiretroviral or PEP use
• Adults tested routinely; parental/guardian consent required for minors per UAE regulations